A retrospective survey of patients with malignant gliomas treated in the neuro-oncological care system under the Universal National Health Insurance program in Taiwan

Yin Cheng Huang, Kuo Chen Wei, Chin Hong Chang, Jen Tsung Yang, Jih Tsun Ho, Chiung Chyi Shen, Chain Fa Su, Der Yang Cho, Hsin I. Ma, Jia Wei Lin, E. Jian Lee, Jionn Jong Wu, Ming Dar Tsai, Cheng Kuei Chang, Shen Long Howng, Chen Nen Chang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In 1995 a government-supported Universal National Health care system was implemented in Taiwan, which in 2008 was available to 98% of the population. This system offers affordable, rapid medical attention. A multi-center retrospective study was conducted to assess the prognosis of malignant glioma patients under this system. In 2005 and 2006, patients at 14 independent neuro-oncology centers with newly diagnosed malignant glioma were enrolled. The patient profile, pathology, treatment modalities, and prognosis were collected by questionnaire at each center. The Taiwan Neuro-Oncology Society was responsible for the data analysis. The overall median survival period, 1-year survival rate, and 2-year survival rate for patients with World Health Organization grade III glioma were 33.8 months, 81.4%, and 58.2%, respectively, and 15 months, 57.3%, and 33.9% in patients with grade IV glioma. The median survival period, 1-year survival rate, and 2-year-survival rate in patients receiving temozolomide adjuvant therapy was 36 months, 84.2%, and 61.8%, respectively, for patients with grade III glioma and 19.8 months, 73.1%, and 43.7%, for patients with grade IV glioma. The universal health care system in Taiwan offers a comparable prognosis with an affordable premium relative to other large series in developed countries.

Original languageEnglish
Pages (from-to)784-788
Number of pages5
JournalJournal of Clinical Neuroscience
Volume18
Issue number6
DOIs
Publication statusPublished - Jun 2011

Keywords

  • Chemotherapy
  • Malignant glioma
  • Radiation therapy
  • Surgery
  • Universal health insurance

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Physiology (medical)

Fingerprint Dive into the research topics of 'A retrospective survey of patients with malignant gliomas treated in the neuro-oncological care system under the Universal National Health Insurance program in Taiwan'. Together they form a unique fingerprint.

  • Cite this

    Huang, Y. C., Wei, K. C., Chang, C. H., Yang, J. T., Ho, J. T., Shen, C. C., Su, C. F., Cho, D. Y., Ma, H. I., Lin, J. W., Lee, E. J., Wu, J. J., Tsai, M. D., Chang, C. K., Howng, S. L., & Chang, C. N. (2011). A retrospective survey of patients with malignant gliomas treated in the neuro-oncological care system under the Universal National Health Insurance program in Taiwan. Journal of Clinical Neuroscience, 18(6), 784-788. https://doi.org/10.1016/j.jocn.2010.10.016